ghk-cu injection dosage clinical studies trial GHK-Cu and Protocol: A Medical Provider's Guide to the GHK-Cu Injection Dosage Chart (50mg)

AOD-9604 is a modified fragment of human growth hormone (hGH), specifically designed to target fat reduction without the growth-promoting effects of traditional hGH

Research Supplies for MOTS-C Hand-picked storage, injection, and recovery supplies paired with MOTS-C protocols

Decision Framework: Which to Choose The choice between AOD-9604 and tesamorelin depends entirely on whether the research wants to engage the GH axis or isolate specific GH effects: Choose AOD-9604 if: Research focuses specifically on lipolytic activity without GH receptor engagement Studies want to avoid IGF-1 elevation and broader GH effects The receptor-independent mechanism is part of the research question Fat metabolism research without confounding GH signaling effects is the goal Choose tesamorelin if: Research focuses on GHRH receptor pharmacology or pituitary GH axis Studies want full GH axis activation including IGF-1 elevation The natural pulsatile GH release pattern is biologically relevant DPP-4-resistant GHRH analog mechanism is the research focus Choose neither (or both) if: Research focuses on different aspects of GH biology Comparative research between upstream and downstream GH peptides is the goal Other GH-related compounds (sermorelin, CJC-1295, ipamorelin) are more relevant see Sermorelin, CJC-1295, and Ipamorelin Research Overview Quality Considerations Both peptides share the same quality framework: Manufactured via Solid-Phase Peptide Synthesis with synthetic amino acids Specific N-terminal modifications incorporated as synthesis steps No animal-derived materials Independent third-party testing by Janoshik Analytical 99% HPLC purity per peptide Mass spectrometry identity confirmation (particularly important for confirming the modifications) For complete quality framework coverage, see How to Verify Peptide Quality and How to Read a Janoshik COA

Can be given once daily or split into twice daily dosing for more consistent support

While therapeutically clearing senescent neurons may not be an appealing approach, the brains immune system is already attempting to rid these harmful cells

Improved firmness, better elasticity, and fading of sun damage typically develop over 8 to 12 weeks